1,191
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Identification of macrophage-related molecular subgroups and risk signature in colorectal cancer based on a bioinformatics analysis

&
Article: 2321908 | Received 20 Nov 2023, Accepted 17 Feb 2024, Published online: 11 Mar 2024

References

  • Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):1–14. doi:10.3322/caac.21654
  • Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi:10.1136/gutjnl-2015-310912
  • Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–573. doi:10.1002/cncr.24760
  • Center MM, Jemal A, Smith RA, et al. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59(6):366–378. doi:10.3322/caac.20038
  • Zhai X, Xue Q, Liu Q, et al. Colon cancer recurrence‑associated genes revealed by WGCNA co‑expression network analysis. Mol Med Rep. 2017;16(5):6499–6505. doi:10.3892/mmr.2017.7412
  • Műzes G, Molnár B, Sipos F. Regulatory T cells in inflammatory bowel diseases and colorectal cancer. World J Gastroenterol. 2012;18(40):5688–5694. doi:10.3748/wjg.v18.i40.5688
  • Waldner M, Schimanski CC, Neurath MF. Colon cancer and the immune system: the role of tumor invading T cells. World J Gastroenterol. 2006;12(45):7233–7238. doi:10.3748/wjg.v12.i45.7233
  • Kießler M, Plesca I, Sommer U, et al. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human Colon cancer. J Immunother Cancer. 2021;9(3):e001813. doi:10.1136/jitc-2020-001813
  • Wang H, Tian T, Zhang J. Tumor-Associated macrophages (TAMs) in colorectal cancer (CRC): from mechanism to therapy and prognosis. Int J Mol Sci. 2021;22(16):8470.
  • Väyrynen JP, Haruki K, Lau MC, et al. The prognostic role of macrophage polarization in the colorectal cancer microenvironment. Cancer Immunol Res. 2021;9(1):8–19. doi:10.1158/2326-6066.CIR-20-0527
  • Kou Y, Li Z, Sun Q, et al. Prognostic value and predictive biomarkers of phenotypes of tumour-associated macrophages in colorectal cancer. Scand J Immunol. 2022;95(4):e13137. doi:10.1111/sji.13137
  • Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14(1):7. doi:10.1186/1471-2105-14-7
  • Canzler S, Hackermüller J. multiGSEA: a GSEA-based pathway enrichment analysis for multi-omics data. BMC Bioinformatics. 2020;21(1):561. doi:10.1186/s12859-020-03910-x
  • Tibshirani R. The lasso method for variable selection in the cox model. Statist Med. 1997;16(4):385–395. doi:10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3
  • Hong K, Cen K, Chen Q, et al. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. Front Immunol. 2023;14:1229541.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557–4566. doi:10.1158/0008-5472.CAN-18-3962
  • Ge P, Wang W, Li L, et al. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer. Biomed Pharmacother. 2019;118:109228. doi:10.1016/j.biopha.2019.109228
  • Wozniakova M, Skarda J, Raska M. The role of tumor microenvironment and immune response in colorectal cancer development and prognosis. Pathol Oncol Res. 2022;28:1610502. doi:10.3389/pore.2022.1610502
  • Malherbe K. Tumor microenvironment and the role of artificial intelligence in breast cancer detection and prognosis. Am J Pathol. 2021;191(8):1364–1373. doi:10.1016/j.ajpath.2021.01.014
  • Xia Y, Rao L, Yao H, et al. Engineering macrophages for cancer immunotherapy and drug delivery. Adv Mater. 2020;32(40):e2002054.
  • Mantovani A, Allavena P, Marchesi F, et al. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21(11):799–820. doi:10.1038/s41573-022-00520-5
  • Li C, Xu X, Wei S, et al. Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. J Immunother Cancer. 2021;9(1):e001341. doi:10.1136/jitc-2020-001341
  • Zhu H, Zheng C, Liu H, et al. Significance of macrophage infiltration in the prognosis of lung adenocarcinoma patients evaluated by scRNA and bulkRNA analysis. Front Immunol. 2022;13:1028440. doi:10.3389/fimmu.2022.1028440
  • Feng Q, Chang W, Mao Y, et al. Tumor-associated macrophages as prognostic and predictive biomarkers for postoperative adjuvant chemotherapy in patients with stage II Colon cancer. Clin Cancer Res. 2019;25(13):3896–3907. doi:10.1158/1078-0432.CCR-18-2076
  • Maekura K, Tsukamoto S, Hamada-Kanazawa M, et al. Rimklb mutation causes male infertility in mice. Sci Rep. 2021;11(1):4604. doi:10.1038/s41598-021-84105-z
  • Yoon HS, Kim HY, Cho KA, et al. Procollagen C-Endopeptidase enhancer 2 secreted by Tonsil-Derived mesenchymal stem cells increases the oxidative burst of promyelocytic HL-60 cells. Biology (Basel). 2022;11(2):255.
  • Zheng Q, Zheng X, Zhang L, et al. The Neuron-Specific protein TMEM59L mediates oxidative Stress-Induced cell death. Mol Neurobiol. 2017;54(6):4189–4200. doi:10.1007/s12035-016-9997-9
  • Boada-Romero E, Letek M, Fleischer A, et al. TMEM59 defines a novel ATG16L1-binding motif that promotes local activation of LC3. Embo J. 2013;32(4):566–582. doi:10.1038/emboj.2013.8
  • Shi C, Zhang L, Chen D, et al. Prognostic value of TMEM59L and its genomic and immunological characteristics in cancer. Front Immunol. 2022;13:1054157. doi:10.3389/fimmu.2022.1054157
  • Zhang M, Su L, Wang W, et al. Endothelial cells regulated by RNF20 orchestrate the proliferation and differentiation of neural precursor cells during embryonic development. Cell Rep. 2022;40(11):111350. doi:10.1016/j.celrep.2022.111350
  • Huang F, Peng Y, Ye Q, et al. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in the cancer genome atlas (TCGA) study. World J Surg Oncol. 2020;18(1):274. doi:10.1186/s12957-020-02049-6
  • Requena T, Cabrera S, Martín-Sierra C, et al. Identification of two novel mutations in FAM136A and DTNA genes in autosomal-dominant familial meniere’s disease. Hum Mol Genet. 2015;24(4):1119–1126. doi:10.1093/hmg/ddu524
  • Hu ZG, Zhang S, Chen YB, et al. DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling. Life Sci. 2020;258:118029. doi:10.1016/j.lfs.2020.118029